Healthcare -
Biotechnology - NASDAQ - US
$ 3.69
2.5 %
$ 39.8 M
Market Cap
-2.07
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
17.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lantern Pharma Inc.
LTRN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart LTRN
EBIT FORECAST
EBIT Forecast Chart LTRN
NET INCOME FORECAST
Net Income Chart LTRN